Legal & General Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.8M | Sell |
|
|||||
|
2025
Q2 | $1.45M | Buy |
|
|||||
|
2025
Q1 | $1.16M | Sell |
|
|||||
|
2024
Q4 | $1.63M | Buy |
|
|||||
|
2024
Q3 | $2.14M | Buy |
|
|||||
|
2024
Q2 | $2.16M | Buy |
|
|||||
|
2024
Q1 | $2.37M | Buy |
|
|||||
|
2023
Q4 | $2.06M | Buy |
|
|||||
|
2023
Q3 | $1.12M | Buy |
|
|||||
|
2023
Q2 | $1.25M | Buy |
|
|||||
|
2023
Q1 | $677K | Buy |
|
|||||
|
2022
Q4 | $767K | Buy |
|
|||||
|
2022
Q3 | $474K | Buy |
|
|||||
|
2022
Q2 | $435K | Sell |
|
|||||
|
2022
Q1 | $572K | Buy |
|
|||||
|
2021
Q4 | $638K | Sell |
|
|||||
|
2021
Q3 | $906K | Buy |
|
|||||
|
2021
Q2 | $204K | Buy |
|
|||||
|
2021
Q1 | $35K | Hold |
|
|||||
|
2020
Q4 | $30K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $56K | Sell |
|
|||||
|
2017
Q4 | $99K | Buy |
|
|||||
|
2017
Q3 | $86K | Hold |
|
|||||
|
2017
Q2 | $74K | Buy |
|
|||||
|
2017
Q1 | $92K | Sell |
|
|||||
|
2016
Q4 | $118K | Buy |
|
|||||
|
2016
Q3 | $96K | Hold |
|
|||||
|
2016
Q2 | $108K | Hold |
|
|||||
|
2016
Q1 | $92K | Buy |
|
|||||
|
2015
Q4 | $351K | Buy |
|
|||||
|
2015
Q3 | $195K | Hold |
|
|||||
|
2015
Q2 | $451K | Buy |
|
|||||
|
2015
Q1 | $477K | Buy |
|
|||||
|
2014
Q4 | $258K | Sell |
|
|||||
|
2014
Q3 | $192K | Buy |
|